Biofrontera Inc. (BFRI)
NASDAQ: BFRI
· Real-Time Price · USD
0.95
0.00 (0.00%)
At close: Aug 14, 2025, 3:59 PM
0.92
-2.91%
After-hours: Aug 14, 2025, 07:30 PM EDT
0.00% (1D)
Bid | 0.92 |
Market Cap | 9.61M |
Revenue (ttm) | 37.99M |
Net Income (ttm) | -11.53M |
EPS (ttm) | -0.81 |
PE Ratio (ttm) | -1.17 |
Forward PE | -4.55 |
Analyst | Buy |
Ask | 1.11 |
Volume | 36,083 |
Avg. Volume (20D) | 191,933 |
Open | 1.06 |
Previous Close | 0.95 |
Day's Range | 0.92 - 1.06 |
52-Week Range | 0.54 - 2.22 |
Beta | 0.52 |
About BFRI
undefined
Industry n/a
Sector n/a
IPO Date n/a
Employees NaN
Stock Exchange n/a
Ticker Symbol BFRI
Website n/a
Analyst Forecast
According to 0 analyst ratings, the average rating for BFRI stock is "n/a." The 12-month stock price forecast is $n/a, which is a decrease of 0% from the latest price.
Stock ForecastsEarnings Surprise
Biofrontera has released their quartely earnings
on Aug 13, 2025:
Next Earnings Release
Biofrontera Inc. is scheduled to release its earnings on
Nov 12, 2025,
during market hours.
Analysts project revenue of ... Unlock content with Pro Subscription
Analysts project revenue of ... Unlock content with Pro Subscription
4 months ago
-16.5%
Biofrontera shares are trading lower after the com...
Unlock content with
Pro Subscription
7 months ago
+6.31%
Biofrontera shares are trading higher after the company announced the last patient completed the 1 year follow-up of study ALA-BCC-CT013 in December 2024.

22 hours ago · seekingalpha.com
Biofrontera Inc. (BFRI) Q2 2025 Earnings Conference Call TranscriptBiofrontera Inc. (NASDAQ:BFRI ) Q2 2025 Earnings Conference August 14, 2025 10:00 AM ET Company Participants Eugene Frederick Leffler - Chief Financial Officer Hermann Luebbert - CEO, President & Chai...